Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes
Abstract Background In the current SARS-CoV-2 pandemic, there has been worldwide debate on the use of corticosteroids in COVID-19. In the recent RECOVERY trial, evaluating the effect of dexamethasone, a reduced 28-day mortality in patients requiring oxygen therapy or mechanical ventilation was shown...
Main Authors: | Judith van Paassen, Jeroen S. Vos, Eva M. Hoekstra, Katinka M. I. Neumann, Pauline C. Boot, Sesmu M. Arbous |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-12-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13054-020-03400-9 |
Similar Items
-
Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study
by: Cheng Ding, et al.
Published: (2020-09-01) -
Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study
by: Rui Huang, et al.
Published: (2021-07-01) -
Corticosteroids in COVID-19: pros and cons
by: Aymen Bahsoun, et al.
Published: (2023-08-01) -
Effect of corticosteroids in patients with COVID-19: a Bayesian network meta-analysis
by: Xing Wang, et al.
Published: (2022-12-01) -
Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital
by: Annalisa Mondi, et al.
Published: (2021-04-01)